Selected research
Industry Research
Antihistamine Drugs Industry Research Report 2026
Market perspective
The global Antihistamine Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Antihistamine Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Antihistamine Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Antihistamine Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Antihistamine Drugs include Akorn, Almirall, Boehringer Ingelheim, Meda Consumer Healthcare, AstraZeneca, Bayer, Pfizer, Merck & Co. and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Antihistamine Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antihistamine Drugs Market by Company
Akorn
Almirall
Boehringer Ingelheim
Meda Consumer Healthcare
AstraZeneca
Bayer
Pfizer
Merck & Co.
Novartis
Johnson & Johnson
Sanofi
Teva Pharmaceutical
Antihistamine Drugs Segment by Type
Prescription-based Antihistamine Drugs
Over-the-counter(OTC) Antihistamine Drugs
Antihistamine Drugs Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Antihistamine Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antihistamine Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antihistamine Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antihistamine Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antihistamine Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antihistamine Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antihistamine Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Prescription-based Antihistamine Drugs
- Over-the-counter(OTC) Antihistamine Drugs
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- Akorn
- Almirall
- Boehringer Ingelheim
- Meda Consumer Healthcare
- AstraZeneca
- Bayer
- Pfizer
- Merck & Co.
- Novartis
- Johnson & Johnson
- Sanofi
- Teva Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Antihistamine Drugs Market Size (2021-2032)
- 2.2.2 Global Antihistamine Drugs Sales (2021-2032)
- 2.2.3 Global Antihistamine Drugs Market Average Price (2021-2032)
- 2.3 Antihistamine Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Prescription-based Antihistamine Drugs
- 2.3.3 Over-the-counter(OTC) Antihistamine Drugs
- 2.4 Antihistamine Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Hospital Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Antihistamine Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Antihistamine Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Antihistamine Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Antihistamine Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Antihistamine Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Antihistamine Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Antihistamine Drugs, Product Type & Application
- 3.8 Global Manufacturers of Antihistamine Drugs, Established Date
- 3.9 Global Antihistamine Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Akorn
- 4.1.1 Akorn Company Information
- 4.1.2 Akorn Business Overview
- 4.1.3 Akorn Antihistamine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Akorn Antihistamine Drugs Product Portfolio
- 4.1.5 Akorn Recent Developments
- 4.2 Almirall
- 4.2.1 Almirall Company Information
- 4.2.2 Almirall Business Overview
- 4.2.3 Almirall Antihistamine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Almirall Antihistamine Drugs Product Portfolio
- 4.2.5 Almirall Recent Developments
- 4.3 Boehringer Ingelheim
- 4.3.1 Boehringer Ingelheim Company Information
- 4.3.2 Boehringer Ingelheim Business Overview
- 4.3.3 Boehringer Ingelheim Antihistamine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Boehringer Ingelheim Antihistamine Drugs Product Portfolio
- 4.3.5 Boehringer Ingelheim Recent Developments
- 4.4 Meda Consumer Healthcare
- 4.4.1 Meda Consumer Healthcare Company Information
- 4.4.2 Meda Consumer Healthcare Business Overview
- 4.4.3 Meda Consumer Healthcare Antihistamine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Meda Consumer Healthcare Antihistamine Drugs Product Portfolio
- 4.4.5 Meda Consumer Healthcare Recent Developments
- 4.5 AstraZeneca
- 4.5.1 AstraZeneca Company Information
- 4.5.2 AstraZeneca Business Overview
- 4.5.3 AstraZeneca Antihistamine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 AstraZeneca Antihistamine Drugs Product Portfolio
- 4.5.5 AstraZeneca Recent Developments
- 4.6 Bayer
- 4.6.1 Bayer Company Information
- 4.6.2 Bayer Business Overview
- 4.6.3 Bayer Antihistamine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bayer Antihistamine Drugs Product Portfolio
- 4.6.5 Bayer Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Company Information
- 4.7.2 Pfizer Business Overview
- 4.7.3 Pfizer Antihistamine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Antihistamine Drugs Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 Merck & Co.
- 4.8.1 Merck & Co. Company Information
- 4.8.2 Merck & Co. Business Overview
- 4.8.3 Merck & Co. Antihistamine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Merck & Co. Antihistamine Drugs Product Portfolio
- 4.8.5 Merck & Co. Recent Developments
- 4.9 Novartis
- 4.9.1 Novartis Company Information
- 4.9.2 Novartis Business Overview
- 4.9.3 Novartis Antihistamine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Novartis Antihistamine Drugs Product Portfolio
- 4.9.5 Novartis Recent Developments
- 4.10 Johnson & Johnson
- 4.10.1 Johnson & Johnson Company Information
- 4.10.2 Johnson & Johnson Business Overview
- 4.10.3 Johnson & Johnson Antihistamine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Johnson & Johnson Antihistamine Drugs Product Portfolio
- 4.10.5 Johnson & Johnson Recent Developments
- 4.11 Sanofi
- 4.11.1 Sanofi Company Information
- 4.11.2 Sanofi Business Overview
- 4.11.3 Sanofi Antihistamine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sanofi Antihistamine Drugs Product Portfolio
- 4.11.5 Sanofi Recent Developments
- 4.12 Teva Pharmaceutical
- 4.12.1 Teva Pharmaceutical Company Information
- 4.12.2 Teva Pharmaceutical Business Overview
- 4.12.3 Teva Pharmaceutical Antihistamine Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Teva Pharmaceutical Antihistamine Drugs Product Portfolio
- 4.12.5 Teva Pharmaceutical Recent Developments
5 Global Antihistamine Drugs Market Scenario by Region
- 5.1 Global Antihistamine Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Antihistamine Drugs Sales by Region: 2021-2032
- 5.2.1 Global Antihistamine Drugs Sales by Region: 2021-2026
- 5.2.2 Global Antihistamine Drugs Sales by Region: 2027-2032
- 5.3 Global Antihistamine Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Antihistamine Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Antihistamine Drugs Revenue by Region: 2027-2032
- 5.4 North America Antihistamine Drugs Market Facts & Figures by Country
- 5.4.1 North America Antihistamine Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Antihistamine Drugs Sales by Country (2021-2032)
- 5.4.3 North America Antihistamine Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Antihistamine Drugs Market Facts & Figures by Country
- 5.5.1 Europe Antihistamine Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Antihistamine Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Antihistamine Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Antihistamine Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Antihistamine Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Antihistamine Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Antihistamine Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Antihistamine Drugs Market Facts & Figures by Country
- 5.7.1 South America Antihistamine Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Antihistamine Drugs Sales by Country (2021-2032)
- 5.7.3 South America Antihistamine Drugs Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Antihistamine Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Antihistamine Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Antihistamine Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Antihistamine Drugs Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Antihistamine Drugs Sales by Type (2021-2032)
- 6.1.1 Global Antihistamine Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Antihistamine Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Antihistamine Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Antihistamine Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Antihistamine Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Antihistamine Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Antihistamine Drugs Sales by Application (2021-2032)
- 7.1.1 Global Antihistamine Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Antihistamine Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Antihistamine Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Antihistamine Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Antihistamine Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Antihistamine Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Antihistamine Drugs Value Chain Analysis
- 8.1.1 Antihistamine Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Antihistamine Drugs Production Mode & Process
- 8.2 Antihistamine Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Antihistamine Drugs Distributors
- 8.2.3 Antihistamine Drugs Customers
9 Global Antihistamine Drugs Analyzing Market Dynamics
- 9.1 Antihistamine Drugs Industry Trends
- 9.2 Antihistamine Drugs Industry Drivers
- 9.3 Antihistamine Drugs Industry Opportunities and Challenges
- 9.4 Antihistamine Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst